Journal: Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Fellow : Pattama T.
9.00 – 10.00 a.m.
I.D. Conference Room, 5th floor, Bhumisiri mangkhalanusorn building
For more, please visit
http://www.idchula.org/_____________________________
นพ.จิรวัฒน์ บุพพันเหรัญ
Jirawat Buppanharun, MD